Loading...

JNJ JOHNSON & JOHNSON Earnings Reports 8-K Filing

JHNS

JNJ

JOHNSON & JOHNSON

(JNJ)

2025 8-K

Business Separation Announc...

Director Appointment

Financial Statements

Earnings Report

Q3 Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Q3 Earnings Report

Earnings Report

Financial Performance

IPO and Disposition of Shares

Earnings and Reorganization...

Amended and Restated By-Law...

Earnings Reports

Earnings Report

Appointment of Director

Meeting with Investment Com...

Acquisition Announcement

Compensation Plan Approval

Resignation of Executive

Earnings Report

Blackout Notice

Earnings Release

IPO of Subsidiary

Departure of Directors

Earnings Reports

Bankruptcy or insolvency

Appointment of Director

Earnings Reports

External Links:

Johnson & Johnson reported a significant increase in sales for the third quarter of 2023, reaching $21.3 billion, up 6.5% from the previous year, with strong performance in its pharmaceutical division.

AI Assistant

JOHNSON & JOHNSON

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.